B cell responses to conjugate and polysaccharide meningococcal vaccines

B cell responses to conjugate and polysaccharide meningococcal vaccines

<p>The primary approach to the control of meningococcal disease remains effective vaccination programmes in susceptible populations. Vaccines against serogroups A, C, W and Y offer broad protection against meningococci and both polysaccharide and conjugate quadrivalent vaccines are licensed fo...

Descripció completa

Dades bibliogràfiques
Autor principal:	Ramasamy, M
Altres autors:	Pollard, A
Format:	Thesis
Idioma:	English
Publicat:	2012
Matèries:	Immunology Vaccinology Meningitis Infectious diseases

Ítems similars

Quadrivalent meningococcal conjugate vaccines
per: Pace, D, et al.
Publicat: (2009)

Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America
per: Pollard, A, et al.
Publicat: (2004)

Global epidemiology of meningococcal disease and vaccine efficacy
per: Pollard, A
Publicat: (2004)

Impact of serogroup A meningococcal conjugate vaccine for Africa
per: James M. Stuart
Publicat: (2018-05-01)

Maintaining protection against invasive bacteria with protein - polysaccharide conjugate vaccines
per: Pollard, A, et al.
Publicat: (2009)

Evaluation of a potential vaccine against hyperinvasive serogroup B Neisseria meningitidis by assessment of the effects of surface-expressed Opacity-associated proteins on the immune system
per: Sadarangani, M
Publicat: (2011)

Vaccine prevention of meningococcal disease, coming soon?
per: Morley, S, et al.
Publicat: (2001)

Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines.
per: Pace, D, et al.
Publicat: (2007)

A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods
per: Warrell, M, et al.
Publicat: (2008)

Comparison of a limiting dilution assay and ELISpot for detection of memory B-cells before and after immunisation with a protein-polysaccharide conjugate vaccine in children
per: Blanchard-Rohner, G, et al.
Publicat: (2010)

Host genetic factors and vaccine-induced immunity to hepatitis B virus infection
per: Hennig, B, et al.
Publicat: (2008)

Control of typhoid fever: evaluating herd protection through public health use of typhoid VI polysaccharide vaccine
per: Ochiai, R
Publicat: (2011)

Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
per: Bauza, K
Publicat: (2012)

The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM197 conjugate vaccine
per: Clutterbuck, E, et al.
Publicat: (2006)

Public policy for meningococcal vaccination
per: J. Claire Cameron
Publicat: (2018-05-01)

Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
per: Elias, SC
Publicat: (2014)

Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
per: Antrobus, R
Publicat: (2014)

New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
per: Alharbi, N
Publicat: (2014)

Development of antimalarial human monoclonal antibodies against Plasmodium falciparum
per: Wang, LT
Publicat: (2022)

B cell response to pneumococcal vaccines
per: Trück, J
Publicat: (2014)

Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response.
per: Matsumiya, M, et al.
Publicat: (2014)

Innate immune responses to tuberculosis vaccines
per: Matsumiya, M
Publicat: (2014)

A randomised study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide - CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge phase
per: Riddell, A, et al.
Publicat: (2007)

Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants
per: Ruggeberg, J, et al.
Publicat: (2007)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
per: Harris, S, et al.
Publicat: (2013)

Understanding vaccine induced protective immunity to Mycobacterium tuberculosis
per: Ronan, E
Publicat: (2011)

Understanding the link between interleukin 17 and vaccine-induced protection in tuberculosis
per: Griffiths, K
Publicat: (2012)

Of mice and MenB: assessing the immune mechanisms underlying meningococcal capsular group B vaccines in mice
per: Sheerin, D
Publicat: (2019)

Characterisation of T cells induced by candidate conserved region HIV-1 vaccines in healthy HIV-1/2 negative volunteers
per: Ahmed, T, et al.
Publicat: (2014)

Vaccines against bacterial meningitis
per: Segal, S, et al.
Publicat: (2004)

Genetics determinants of vaccine responses
per: O'Connor, D
Publicat: (2014)

The design and development of an HIV-1 vaccine to elicit a broadly neutralising antibody response
per: Wan, L, et al.
Publicat: (2012)

Evaluation of the immunological mechanisms induced by mycobacteria and the potential effect this may have on immunity induced by tuberculosis vaccines
per: Poyntz, HC
Publicat: (2012)

Novel adenoviral vectored vaccines and the implications of viral diversity in therapeutic strategies against Hepatitis C Virus infection
per: Kelly, C
Publicat: (2013)

Long term efficacy of a pre-erythrocytic malaria vaccine and correlates of protection in children residing in a malaria endemic country
per: Olotu, A
Publicat: (2013)

Evaluation of the immunogenicity of a promising vaccine regimen to identify immune correlates of protection
per: Pinpathomrat, N
Publicat: (2018)

HIV-specific interleukin-10 responses and immune modulation
per: Clutton, G
Publicat: (2012)

Enhancing the efficacy of viral vector blood-stage malaria vaccines
per: Forbes, E
Publicat: (2011)

Developing novel blood-stage malaria vaccines
per: Douglas, AD
Publicat: (2015)

Vi polysaccharide-protein conjugate vaccine for the prevention of typhoid fever in children: hope or hype?
per: Pulickal, A, et al.
Publicat: (2007)